Adir Et Compagnie

Les Laboratoires Servier

Alain Gobert

Mark Millan

Gilbert Lavielle

Jean-Louis Peglion

Bertrand Goument

Olivier Muller

Adrian Newman-Tancredi

Aimee Dessinges

Guillaume De Nanteuil

Alex Cordi

Bernard Portevin

Jean-Michel Lacoste

Philippe Gloanec

Bernard Cimetiere

Valerie Audinot

Jean-Claude Ortuno

Jean-Michel Rivet

Clotilde Mannoury La Cour

Benjamin Di Cara

A compound selected from those of formula (I): wherein: Medical products containing the same which are useful in the treatment of conditions requiring a serotonin reuptake inhibitor and/or NKantagonist.

Indanyl-piperazine compounds

A compound of formula (I): wherein: Rand Rtogether form a benzo ring optionally substituted by halogen or by alkyl, alkoxy, cyano, nitro, hydroxy, amino, alkylamino, dialkylamino or trifluoromethyl, and Rrepresents hydrogen, or Rrepresents hydrogen, and Rand Rtogether form a benzo ring optionally substituted by halogen or by alkyl, alkoxy, cyano, nitro, hydroxy, amino, alkylamino, dialkylamino or trifluoromethyl, its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicaments.

Indoline compounds

Benzoindoline compounds

Indoline compounds, a process for their preparation and pharmaceutical compositions containing them

Cyano-indole serotonin-reuptake inhibitor compounds

The invention relates to a compound of formula (I): ##STR1## wherein: A represents an optionally substituted benzene ring,

Imidazoline compounds

New 2-aminoindan compounds of formula: ##STR1## wherein: n, Ar, R, E, X.sub.1, X.sub.2, X.sub.3, and X.sub.4 are as defined in the description, in the form of a racemic mixture and in the form of optical isomers, and physiologically-tolerable acid addition salts thereof. The products of the invention are useful as medicaments and exhibit selective binding affinity for the 5HT.sub.1B receptors.

2-aminoindan compounds as 5HT.sub.1B antagonists

New N-arylpiperidine compounds of formula: ##STR1## wherein: A, m, R, E, n and Ar are as defined in the description, the isomers thereof and the addition salts thereof with a pharmaceutically acceptable acid, and medicinal products containing the same are useful in the treatment of disorders involving the serotininergic system.

N-aryl piperidine compounds as 5HT.sub.1B antagonists

A compound selected from those of formula: ##STR1## wherein: A--B, n, D and E are as defined in the specification, their racemic mixtures, and their optical isomers, and also the physiologically tolerable salts thereof with appropriate acids. The products of the invention may be used therapeutically.

Piperazine compounds

A compound selected from those of formula: ##STR1## wherein: A-B, n, D and E are as defined in the specification,

Piperazine, piperidine and 1,2,5,6-tetrahydropyridine

Growing community of inventors

Rueil-Malmaison, France

Alain Gobert